Stefan Oschmann

Independent Board Director
Stefan Oschmann was Chairman of the Executive Board and CEO of Merck until 2021. He drove the transformation of the Biopharma business by optimizing its cost structures and improving the efficiency of its research & development model. Before joining Merck, Stefan Oschmann worked for the U.S. pharma company MSD, where he served in a range of senior executive positions.
Videos

Rethinking the Future of Science

Digital Europe After Covid-19: Hotspot or Notspot?

Technology for Human Progress
Articles

Key Insights: What We Learned at DLD All Stars
